Federal Register / Vol. 86, No. 115 / Thursday, June 17, 2021 / Notices 32285 

partially exclusive license. Objections 

submitted in response to this notice will 

not be made available to the public for 

inspection and, to the extent permitted 

by law, will not be released under the 

Freedom of Information Act. 

FOR FURTHER INFORMATION CONTACT: 

Written objections relating to the 

prospective license or requests for 

further information may be submitted to 

Agency Counsel for Intellectual 

Property, NASA Headquarters at Email: 

hq-patentoffice@mail.nasa.gov. 

Questions may be directed to Helen 

Galus at (202) 358–3437. 

SUPPLEMENTARY INFORMATION: NASA 

intends to grant an exclusive, coexclusive, or partially exclusive patent 

license in the United States to practice 

the inventions described and claimed 

in: US 8,735,116 B2, High-Density Spot 

Seeding for Tissue Model Formation 

and US 9,243,223 B2, High-Density Spot 

Seeding for Tissue Model Formation to 

BSK Health Partners, LLC. having its 

principal place of business in North 

Richland Hills, Texas. The fields of use 

may be limited. NASA has not yet made 

a final determination to grant the 

requested license and may deny the 

requested license even if no objections 

are submitted within the comment 

period. 

This notice of intent to grant an 

exclusive, co-exclusive or partially 

exclusive patent license is issued in 

accordance with 35 U.S.C. 209(e) and 37 

CFR 404.7(a)(1)(i). The patent rights in 

these inventions have been assigned to 

the United States of America as 

represented by the Administrator of the 

National Aeronautics and Space 

Administration. The prospective license 

will comply with the requirements of 35 

U.S.C. 209 and 37 CFR 404.7. 

Information about other NASA 

inventions available for licensing can be 

found online at http://

technology.nasa.gov. 

Helen M. Galus, 

Agency Counsel for Intellectual Property. 

[FR Doc. 2021–12756 Filed 6–16–21; 8:45 am] 

BILLING CODE 7510–13–P 

NUCLEAR REGULATORY 

COMMISSION 

Advisory Committee on the Medical 

Uses of Isotopes: Meeting Notice 

AGENCY: U.S. Nuclear Regulatory 

Commission. 

ACTION: Notice of meeting. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) will convene a 

public teleconference meeting of the 

Advisory Committee on the Medical 

Uses of Isotopes (ACMUI) on July 15, 

2021, to discuss the ACMUI 

Subcommittee on Extravasations and 

Medical Event Reporting draft report on 

the NRC staff’s preliminary evaluation 

of whether extravasations merits a 

change in medical event reporting. The 

meeting agenda is subject to change. 

Meeting information, including a copy 

of the agenda and related documents, 

will be available on the ACMUI’s 

Meetings and Related Documents web 

page at https://www.nrc.gov/reading-rm/ 

doc-collections/acmui/meetings/ 

2021.html. The agenda and related 

meeting documents may also be 

obtained by contacting Ms. Kellee 

Jamerson using the information below. 

DATES: The teleconference meeting will 

be held on Thursday, July 15, 2021, 1:00 

p.m. to 3:00 p.m. Eastern Daylight Time. 

Date Webinar information 

July 15, 2021 .... Link: https://

usnrc.webex.com. 

Event number: 199 085 

4780. 

Public Participation: The meeting will 

also be held as a webinar. Any member 

of the public who wishes to participate 

in any portion of this meeting should 

register in advance of the meeting by 

accessing the provided link and event 

number above. Upon successful 

registration, an email confirmation will 

be generated providing the telephone 

bridge line and a link to join the 

webinar on the day of the meeting. 

Members of the public should also 

monitor the NRC’s Public Meeting 

Schedule at https://www.nrc.gov/pmns/ 

mtg for any meeting updates. If there are 

any questions regarding the meeting, 

please contact Ms. Jamerson using the 

information below. 

Contact Information: Kellee Jamerson, 

email: Kellee.Jamerson@nrc.gov, 

telephone: 301–415–7408. 

Conduct of the Meeting 

The ACMUI Chair, Darlene F. Metter, 

M.D., will preside over the meeting. Dr. 

Metter will conduct the meeting in a 

manner that will facilitate the orderly 

conduct of business. The following 

procedures apply to public participation 

in the meeting: 

1. Persons who wish to provide a 

written statement should submit an 

electronic copy to Ms. Jamerson at the 

contact information listed above. All 

written statements must be received by 

July 12, 2021, three business days prior 

to the meeting, and must pertain to the 

topics on the agenda for the meeting. 

2. Questions and comments from 

members of the public will be permitted 

during the meeting, at the discretion of 

the ACMUI Chairman. 

3. The draft transcript and meeting 

summary will be available on ACMUI’s 

website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/ 

2021.html on or about August 31, 2021. 

4. Persons who require special 

services, such as those for the hearing 

impaired, should notify Ms. Jamerson of 

their planned participation. 

This meeting will be held in 

accordance with the Atomic Energy Act 

of 1954, as amended (primarily Section 

161a); the Federal Advisory Committee 

Act (5 U.S.C. App); and the 

Commission’s regulations in 10 CFR 

part 7. 

Dated at Rockville, Maryland this 14th day 

of June, 2021. 

For the U.S. Nuclear Regulatory 

Commission. 

Russell E. Chazell, 

Federal Advisory Committee Management 

Officer. 

[FR Doc. 2021–12767 Filed 6–16–21; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[Docket No. 40–8907; NRC–2019–0026] 

United Nuclear Corporation Church 

Rock Project 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Draft environmental impact 

statement; reopening of comment 

period. 

SUMMARY: On November 13, 2020, the 

U.S. Nuclear Regulatory Commission 

(NRC) issued for public comment a draft 

Environmental Impact Statement (EIS) 

for United Nuclear Corporation’s (UNC) 

license amendment request. The public 

comment period closed on May 27, 

2021. The NRC has decided to re-open 

the public comment period to allow 

more time for members of the public to 

develop and submit their comments. 

UNC is requesting authorization to 

amend its license (SUA–1475) to 

excavate approximately 1 million cubic 

yards (CY) of mine waste from the 

Northeast Church Rock Mine Site and 

dispose of it at the existing mill site in 

McKinley County, New Mexico. The 

NRC plans to hold a public meeting in 

the future to promote full understanding 

of the contemplated action and facilitate 

public comment. 

DATES: The comment period for the 

document published on November 13, 


lotter on DSK11XQN23PROD with NOTICES1